Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(PET Pharmacokinetics). Showing records 1 – 6 of 6 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Universiteit Utrecht

1. Boss, D.S. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.

Degree: 2009, Universiteit Utrecht

 With the emergence of novel, rationally designed anti-cancer drugs there is also a need for novel endpoints when evaluating these drugs in clinical trials. The… (more)

Subjects/Keywords: Farmacie; Drug Development; PET/CT; Phase I studies; Pharmacokinetics; Pharmacodynamics; Clinical trials; Cancer; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Boss, D. S. (2009). Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/37369

Chicago Manual of Style (16th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Doctoral Dissertation, Universiteit Utrecht. Accessed January 20, 2021. http://dspace.library.uu.nl:8080/handle/1874/37369.

MLA Handbook (7th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Web. 20 Jan 2021.

Vancouver:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2009. [cited 2021 Jan 20]. Available from: http://dspace.library.uu.nl:8080/handle/1874/37369.

Council of Science Editors:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Doctoral Dissertation]. Universiteit Utrecht; 2009. Available from: http://dspace.library.uu.nl:8080/handle/1874/37369


Virginia Commonwealth University

2. McDonagh, Philip R, III. Radioprotective Cerium Oxide Nanoparticles: Molecular Imaging Investigations of CONPs’ Pharmacokinetics, Efficacy, and Mechanisms of Action.

Degree: PhD, Clinical and Translational Sciences, 2016, Virginia Commonwealth University

  Cerium oxide nanoparticles (CONPs) are being investigated for several anti-oxidant applications in medicine. One of their most promising applications is as a radioprotective drug,… (more)

Subjects/Keywords: cerium oxide nanoparticles; nanomedicine; molecular imaging; PET imaging; pharmacokinetics; radioprotection; Nanomedicine; Translational Medical Research

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

McDonagh, Philip R, I. (2016). Radioprotective Cerium Oxide Nanoparticles: Molecular Imaging Investigations of CONPs’ Pharmacokinetics, Efficacy, and Mechanisms of Action. (Doctoral Dissertation). Virginia Commonwealth University. Retrieved from https://doi.org/10.25772/RSGK-C791 ; https://scholarscompass.vcu.edu/etd/4314

Chicago Manual of Style (16th Edition):

McDonagh, Philip R, III. “Radioprotective Cerium Oxide Nanoparticles: Molecular Imaging Investigations of CONPs’ Pharmacokinetics, Efficacy, and Mechanisms of Action.” 2016. Doctoral Dissertation, Virginia Commonwealth University. Accessed January 20, 2021. https://doi.org/10.25772/RSGK-C791 ; https://scholarscompass.vcu.edu/etd/4314.

MLA Handbook (7th Edition):

McDonagh, Philip R, III. “Radioprotective Cerium Oxide Nanoparticles: Molecular Imaging Investigations of CONPs’ Pharmacokinetics, Efficacy, and Mechanisms of Action.” 2016. Web. 20 Jan 2021.

Vancouver:

McDonagh, Philip R I. Radioprotective Cerium Oxide Nanoparticles: Molecular Imaging Investigations of CONPs’ Pharmacokinetics, Efficacy, and Mechanisms of Action. [Internet] [Doctoral dissertation]. Virginia Commonwealth University; 2016. [cited 2021 Jan 20]. Available from: https://doi.org/10.25772/RSGK-C791 ; https://scholarscompass.vcu.edu/etd/4314.

Council of Science Editors:

McDonagh, Philip R I. Radioprotective Cerium Oxide Nanoparticles: Molecular Imaging Investigations of CONPs’ Pharmacokinetics, Efficacy, and Mechanisms of Action. [Doctoral Dissertation]. Virginia Commonwealth University; 2016. Available from: https://doi.org/10.25772/RSGK-C791 ; https://scholarscompass.vcu.edu/etd/4314


University of Michigan

3. Joshi, Aniket. Improved Quantitative Methods for Multiple Neuropharmacological Non-Invasive Brain PET Studies.

Degree: PhD, Biomedical Engineering, 2008, University of Michigan

 Positron emission tomography (PET) is a medical imaging modality offering a powerful tool for brain research by mapping of in vivo neuropharmacological functions such as… (more)

Subjects/Keywords: Positron Emission Tomography; PET Pharmacokinetics; PET Kinetic Modeling; Neuropharamacological Measurements Using PET; Neuroimaging; PET for Clinical Diagnosis and Drug Discovery; Radiology; Health Sciences

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Joshi, A. (2008). Improved Quantitative Methods for Multiple Neuropharmacological Non-Invasive Brain PET Studies. (Doctoral Dissertation). University of Michigan. Retrieved from http://hdl.handle.net/2027.42/61729

Chicago Manual of Style (16th Edition):

Joshi, Aniket. “Improved Quantitative Methods for Multiple Neuropharmacological Non-Invasive Brain PET Studies.” 2008. Doctoral Dissertation, University of Michigan. Accessed January 20, 2021. http://hdl.handle.net/2027.42/61729.

MLA Handbook (7th Edition):

Joshi, Aniket. “Improved Quantitative Methods for Multiple Neuropharmacological Non-Invasive Brain PET Studies.” 2008. Web. 20 Jan 2021.

Vancouver:

Joshi A. Improved Quantitative Methods for Multiple Neuropharmacological Non-Invasive Brain PET Studies. [Internet] [Doctoral dissertation]. University of Michigan; 2008. [cited 2021 Jan 20]. Available from: http://hdl.handle.net/2027.42/61729.

Council of Science Editors:

Joshi A. Improved Quantitative Methods for Multiple Neuropharmacological Non-Invasive Brain PET Studies. [Doctoral Dissertation]. University of Michigan; 2008. Available from: http://hdl.handle.net/2027.42/61729

4. Kouwenberg, J.J.M. (author). Pharmacokinetics and Dosimetry of Gallium-68 labelled Sarabesin 3 for Prostate Cancer.

Degree: 2015, Delft University of Technology

 Objective: Prostate cancer remains one of the most prevalent forms of cancer in men aged over 65 years, with yearly around 11,200 new cases and… (more)

Subjects/Keywords: prostate cancer; sarabesin; pharmacokinetics; monte carlo; PET; tracer

…of PET/CT scans, venous and urine samples for a period of approximately 4 hours. Slices of… …was measured. 2. Pharmacokinetic Modeling 2.1. Quantitative PET Measurement All scans… …corresponding to the respective PET scan using PMod as shown in Figure 1. Spots assessed by an… …with their 7 Pharmacokinetics and Dosimetry of Ga-68 labelled Sarabesin 3 for Prostate Cancer… …are registered trademarks of The MathWorks, Inc. 8 Pharmacokinetics and Dosimetry of Ga-68… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kouwenberg, J. J. M. (. (2015). Pharmacokinetics and Dosimetry of Gallium-68 labelled Sarabesin 3 for Prostate Cancer. (Masters Thesis). Delft University of Technology. Retrieved from http://resolver.tudelft.nl/uuid:81a32de2-5f74-4582-ab23-079a8db80483

Chicago Manual of Style (16th Edition):

Kouwenberg, J J M (author). “Pharmacokinetics and Dosimetry of Gallium-68 labelled Sarabesin 3 for Prostate Cancer.” 2015. Masters Thesis, Delft University of Technology. Accessed January 20, 2021. http://resolver.tudelft.nl/uuid:81a32de2-5f74-4582-ab23-079a8db80483.

MLA Handbook (7th Edition):

Kouwenberg, J J M (author). “Pharmacokinetics and Dosimetry of Gallium-68 labelled Sarabesin 3 for Prostate Cancer.” 2015. Web. 20 Jan 2021.

Vancouver:

Kouwenberg JJM(. Pharmacokinetics and Dosimetry of Gallium-68 labelled Sarabesin 3 for Prostate Cancer. [Internet] [Masters thesis]. Delft University of Technology; 2015. [cited 2021 Jan 20]. Available from: http://resolver.tudelft.nl/uuid:81a32de2-5f74-4582-ab23-079a8db80483.

Council of Science Editors:

Kouwenberg JJM(. Pharmacokinetics and Dosimetry of Gallium-68 labelled Sarabesin 3 for Prostate Cancer. [Masters Thesis]. Delft University of Technology; 2015. Available from: http://resolver.tudelft.nl/uuid:81a32de2-5f74-4582-ab23-079a8db80483


University of Lund

5. Sydoff, Marie. Quantification Methods for Clinical Studies in Nuclear Medicine - Applications in AMS, PET/CT and SPECT/CT.

Degree: 2013, University of Lund

 An essential part of the development of new radiopharmaceuticals for use in diagnostic nuclear medicine is the determination of its biokinetic properties. The uptake and… (more)

Subjects/Keywords: Radiology, Nuclear Medicine and Medical Imaging; Nuclear Medicine; AMS; PET/CT; SPECT/CT; dosimetry; internal dosimetry; quantification; activity quantification; volume delineation; radiation; biokinetics; pharmacokinetics; biodistribution

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sydoff, M. (2013). Quantification Methods for Clinical Studies in Nuclear Medicine - Applications in AMS, PET/CT and SPECT/CT. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/4057774 ; https://portal.research.lu.se/ws/files/5942884/4058481.pdf

Chicago Manual of Style (16th Edition):

Sydoff, Marie. “Quantification Methods for Clinical Studies in Nuclear Medicine - Applications in AMS, PET/CT and SPECT/CT.” 2013. Doctoral Dissertation, University of Lund. Accessed January 20, 2021. https://lup.lub.lu.se/record/4057774 ; https://portal.research.lu.se/ws/files/5942884/4058481.pdf.

MLA Handbook (7th Edition):

Sydoff, Marie. “Quantification Methods for Clinical Studies in Nuclear Medicine - Applications in AMS, PET/CT and SPECT/CT.” 2013. Web. 20 Jan 2021.

Vancouver:

Sydoff M. Quantification Methods for Clinical Studies in Nuclear Medicine - Applications in AMS, PET/CT and SPECT/CT. [Internet] [Doctoral dissertation]. University of Lund; 2013. [cited 2021 Jan 20]. Available from: https://lup.lub.lu.se/record/4057774 ; https://portal.research.lu.se/ws/files/5942884/4058481.pdf.

Council of Science Editors:

Sydoff M. Quantification Methods for Clinical Studies in Nuclear Medicine - Applications in AMS, PET/CT and SPECT/CT. [Doctoral Dissertation]. University of Lund; 2013. Available from: https://lup.lub.lu.se/record/4057774 ; https://portal.research.lu.se/ws/files/5942884/4058481.pdf

6. Boss, D.S. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.

Degree: 2009, University Utrecht

 With the emergence of novel, rationally designed anti-cancer drugs there is also a need for novel endpoints when evaluating these drugs in clinical trials. The… (more)

Subjects/Keywords: Drug Development; PET/CT; Phase I studies; Pharmacokinetics; Pharmacodynamics; Clinical trials; Cancer; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Boss, D. S. (2009). Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. (Doctoral Dissertation). University Utrecht. Retrieved from https://dspace.library.uu.nl/handle/1874/37369 ; URN:NBN:NL:UI:10-1874-37369 ; 1874/37369 ; urn:isbn:9789490122643 ; URN:NBN:NL:UI:10-1874-37369 ; https://dspace.library.uu.nl/handle/1874/37369

Chicago Manual of Style (16th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Doctoral Dissertation, University Utrecht. Accessed January 20, 2021. https://dspace.library.uu.nl/handle/1874/37369 ; URN:NBN:NL:UI:10-1874-37369 ; 1874/37369 ; urn:isbn:9789490122643 ; URN:NBN:NL:UI:10-1874-37369 ; https://dspace.library.uu.nl/handle/1874/37369.

MLA Handbook (7th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Web. 20 Jan 2021.

Vancouver:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Internet] [Doctoral dissertation]. University Utrecht; 2009. [cited 2021 Jan 20]. Available from: https://dspace.library.uu.nl/handle/1874/37369 ; URN:NBN:NL:UI:10-1874-37369 ; 1874/37369 ; urn:isbn:9789490122643 ; URN:NBN:NL:UI:10-1874-37369 ; https://dspace.library.uu.nl/handle/1874/37369.

Council of Science Editors:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Doctoral Dissertation]. University Utrecht; 2009. Available from: https://dspace.library.uu.nl/handle/1874/37369 ; URN:NBN:NL:UI:10-1874-37369 ; 1874/37369 ; urn:isbn:9789490122643 ; URN:NBN:NL:UI:10-1874-37369 ; https://dspace.library.uu.nl/handle/1874/37369

.